These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2687814)

  • 1. Alpha interferon: progress and perspectives in the biotherapy of chronic myelogenous leukemia.
    Habermann TM
    Oncol Nurs Forum; 1989; 16(6 Suppl):8-11. PubMed ID: 2687814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha interferon: perspectives in the biotherapy of chronic myelogenous leukemia.
    Terebelo HR
    Oncol Nurs Forum; 1991; 18(1 Suppl):5-9. PubMed ID: 1997975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
    Urabe A
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
    Skotnicki AB; Wolska-Smoleń T
    Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
    Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
    Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations.
    O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M
    Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of interferon in the treatment of chronic myelogenous leukemia.
    Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):3-7. PubMed ID: 7992097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: preliminary results.
    Reiffers J; Cahn JY; Montastruc M; Caillot D; Souillet G; Leblond V; Troncy J; Faberes C
    Stem Cells; 1993 Oct; 11 Suppl 3():23-4. PubMed ID: 7905322
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on therapeutic options for chronic myelogenous leukemia.
    Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):31-6. PubMed ID: 2197731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia].
    Iványi JL; Marton E; Kereskai L; Kiss Z; Pajor L
    Orv Hetil; 2000 Nov; 141(47):2527-33. PubMed ID: 11143285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alfa has become a standard in the treatment of chronic myelogenous leukemia.
    Freund M; Huber C
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-5. PubMed ID: 8235694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of interferon-alpha in treatment of chronic myeloid leukemia].
    Thaler J
    Acta Med Austriaca; 1993; 20(3):65-9. PubMed ID: 8368048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of chronic myelogenous leukemia in the interferon era.
    Giralt S; Kantarjian H; Talpaz M
    Semin Hematol; 1995 Apr; 32(2):152-8. PubMed ID: 7652582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic therapy of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; Gutterman J
    Oncology (Williston Park); 1987 Sep; 1(7):35-40, 48-9, 52. PubMed ID: 3152810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
    Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
    Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia.
    Rodriguez J; Cortes J; Talpaz M; O'Brien S; Smith TL; Rios MB; Kantarjian H
    Clin Cancer Res; 2000 Jan; 6(1):147-52. PubMed ID: 10656443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.